Join our webinar on FDA's final rule for cancer labs

🚨 Time’s almost up! In just 2 days, at 1 PM ET, Sheila D. Walcoff, JD, is diving into the complexities of the FDA's Final Rule for Oncology LDTs. Don’t miss out on this vital session where you'll gain the insights needed to steer your cancer lab through the latest regulations. Get your spot now and be ready to navigate the future with confidence! 🧬💼 🔗 Join the webinar: https://bit.ly/3YFFI3U 🤝 G2 Intelligence #LDT #FDA #Oncology #CancerDiagnosis

Stay ahead in oncology with the latest FDA approvals and upcoming PDUFA dates! Discover valuable insights and real-time market intelligence with LARVOL PULSE—your go-to platform for tracking regulatory trends in cancer research. Catch up on past FDA oncology approvals here: https://bit.ly/3Oc6zhl #LARVOL #CancerResearch #FDAApprovals #PDUFA #LARVOLPULSE #OncologyInsights #RealTimeUpdates

Adopting flexible and adaptive trial designs in early phase oncology studies can result in safer, more informed decision-making – lowering risk and improving subject safety. In this insight brief, we explore the specific challenges that sponsors need to be aware of when executing early phase oncology trials. Download now. https://bit.ly/3W9tSgP #oncology #clinicaltrials #earlyphaseoncology

🔔 📢 NEW PUBLICATION: Interview Article - #Collaboration and Partnerships in Accelerating #Cancer Drug Development The Cancer Drug Development Forum (CDDF) is delighted to announce that Prof. Jaap Verweij and Prof. Ruth Plummer’s article, “Collaboration and Partnerships in Accelerating #Cancer Drug Development” has been published in the April edition of Open Access Government. In this interview article, the CDDF board members discuss key milestones in #oncology research and care, as well as the obstacles that need to be tackled to improve #EquitableAccess to #CancerTreatment and trials. 🔶 Read the full article here: https://lnkd.in/ezitXaf4 #cancerpatients #oncologyresearch #CDDF #innovation

Enhance your knowledge of the safety and efficacy of FDA approved and investigational HER2-targeted agents for the treatment of HER2-mutant NSCLC with our on-demand CME webcast. Stream now: https://okt.to/in93l4 #CME #cmeeducation #NSCLC #LungCancer #LungCancerAwareness #fda #oncologyCME #Oncology

Stay ahead with our in-depth analysis of October 2024 FDA approvals and upcoming PDUFA dates for oncology products.    Discover the insights from LARVOL Pulse - your go-to for real-time market intelligence and regulatory trends in cancer research.   Discover more 👉 https://bit.ly/4canQRC   #LARVOL #FDA #Oncology #CancerResearch #PDUFA #LARVOLPulse

🚨 Upcoming Webinar Alert! 🚨 Join us live on September 5th at 1 PM EST as Sheila D. Walcoff, JD, breaks down how cancer labs can navigate the FDA's final rule on oncology LDTs. If you're in the field, this is a must-attend event to ensure your lab stays compliant and ahead of the curve. 🔗 Save your spot now: https://bit.ly/3YFFI3U #CancerResearch #Oncology #ClinicalLabs #WebinarAlert #LabCompliance

The FDA has granted accelerated approval for our targeted treatment-based regimen for first-line treatment of BRAF V600E-mutant metastatic #ColorectalCancer (mCRC).     Thank you to the patients, Investigators and Pfizer Oncology team for continuing to advance the next generation of cancer breakthroughs, so we can realize our vision of helping people with cancer live better and longer lives.     Read the full announcement: https://lnkd.in/ejPWwAYg

#ICYMI: A panelist of experts discussed how real world data (RWD) is transforming precision oncology during our recent webinar, "Searching in a More Complete Haystack: Using Real World Data to Guide Precision Oncology Drug Development." Read the summary and key takeaways: https://buff.ly/3ZfjiVW. Watch the full webinar recording: https://buff.ly/3VeOnaL #RWE #RWD #Oncology #DrugDevelopment #PrecisionOncology #RealWorldEvidence #RealWorldData #Biomarket #Cancer

🚨 Upcoming Webinar Alert! 🚨 Join us live on September 5th at 1 PM EST as Sheila D. Walcoff, JD, breaks down how cancer labs can navigate the FDA's final rule on oncology LDTs.  If you're in the field, this is a must-attend event to ensure your lab stays compliant and ahead of the curve. 🔗 Save your spot now: https://bit.ly/3YFFI3U #CancerResearch #Oncology #ClinicalLabs #WebinarAlert #LabCompliance